Overview
- 20 inspections across 20 sites are on record.
- 11 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2020-01-31.
At a glance
Inspections
20
Sites
20
Observations
11
Career since
Jun 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Mp Pharma Services Inc | 31 Jan 2020 | Human Drugs | |
| OpAns, LLC | 24 Jan 2020 | Human Drugs | |
| Amphastar Pharmaceuticals, Inc. | 21 Nov 2019 | Human Drugs | |
| MedPharm Manufacturing Services LLC | 27 Sep 2019 | Human Drugs | |
| Strides Pharma, Inc. | 23 Aug 2019 | Human Drugs |
Sites inspected
Mp Pharma Services IncDurham, United States1 insp.
OpAns, LLCDurham, United States1 insp.
Amphastar Pharmaceuticals, Inc.Rancho Cucamonga, United States1 insp.
MedPharm Manufacturing Services LLCDurham, United States1 insp.
Strides Pharma, Inc.Chestnut Ridge, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Benton M Ketron1 shared
Betsy C Galliher1 shared
Iris C Macinnes1 shared
Yvette M Lacour-Davis1 shared
Linda M Cherry1 shared
Xiaohan Cai1 shared
Karen M Montgomery1 shared
Himanshu Gupta1 shared
Stephen T Hansen1 shared
Full investigator report
Get the verbatim findings behind Srinivas Chennamaneni's 11 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site